(Q37991066)

26 August 2017

title

Recent developments in our understanding of the antiphospholipid syndrome (English)

1 reference

26 August 2017

P G De Groot

1

1 reference

26 August 2017

J C M Meijers

series ordinal

2

1 reference

26 August 2017

R T Urbanus

series ordinal

3

1 reference

26 August 2017

publication date

6 March 2012

1 reference

International Journal of Laboratory Hematology

26 August 2017

published in

1 reference

26 August 2017

volume

34

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

223-231

1 reference

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

β₂-glycoprotein I: a novel component of innate immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

The primary, secondary, catastrophic, and seronegative variants of the antiphospholipid syndrome: a personal history long in the making

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

β(2) -Glycoprotein I: evolution, structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

beta(2)-glycoprotein I protects J774A.1 macrophages and human coronary artery smooth muscle cells against apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid syndrome: interpretation of laboratory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid antibodies, antiphospholipid syndrome and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Impaired thrombin generation in beta 2-glycoprotein I null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid syndrome (APS): where does it come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2012.01414.X

10.1111/J.1751-553X.2012.01414.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference